Vertex Pharmaceuticals (VRTX)

EBITDA Margin

43.60%

TTM · Period ending:

VRTX logo

VRTX EBITDA Margin

Latest reported43.60%
VRTX EBITDA Margin (-178.26% → 43.60%)
High-resolution chart · PNG

VRTX ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
40.302%
4.4128%
46.6623%
49.6658%
38.5179%
52.9267%
37.4833%
23.1914%
4.1492%
4.4334%
-39.8369%
-103.1598%
-45.7726%
2.7807%
9.4949%
-491.6593%
-586.8544%
-242.8366%
-193.5632%
-92.2179%
-71.1349%
-104.747%
-382.5906%
-76.3901%
-57.9957%
-31.5525%
-71.9156%
-97.2973%
-35.6164%
-272.9323%
-103.1674%
-87.7551%
18.2796%
-189.4737%
-118.75%
-178.2609%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.